Clinical updates, including trial initiations, enrollment status and data readouts and publications: ABM, Fibrogen, Golden.

Biopharmas raising money in public or private financings, including: Galmed, Morphic, Onkai.

New hires and promotions in the biopharma industry, including: Acelink, Aprea, Clearmind, Frontier Medicines, Inceptor, Incyte, Laronde.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cumulus Neuroscience, Norlase, Nucleix.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Insulet, Tidepool.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Dermasensor, Know Labs.

Med-tech firms raising money in public or private financings, including: Augment Therapy, Opgen, Soligenix.

New hires and promotions in the med-tech industry, including: Baxter, Prostatype.

These graphs compare the performance of the biotech stocks for all of 2023 using the BioWorld Stock Indicator and the Nasdaq Biotech Index.

Year-to-date money raised in public, private and other financings of biopharma companies.